Neomed Labs Pacific Biomarkers PAIRimmune are now Nexelis
News, Events & Publications × clear filter

or filter by:

subscribe now

Press Release

NEOMED-LABS and Public Health England Announce a Strategic Agreement

June 27, 2019 | Press Release

Laval, Quebec and Porton, United Kingdom, June 27 2019 – NEOMED-LABS and Public Health England’s (PHE) National Infection Service are […]

read more

NEOMED-LABS / Pacific Biomarkers Strengthens its Immunology Franchise by Acquiring PAIRimmune

June 6, 2019 | Press Release

LAVAL, QC, June 6, 2019 – The recently merged NEOMED-LABS / Pacific Biomarkers (NLPBI), a leading immunology centric service provider specialized […]

read more

Timothy McGrath Appointed Chief Operating Officer of Newly Merged NEOMED-LABS / Pacific Biomarkers

March 28, 2019 | Press Release

LAVAL, QC, and SEATTLE, WA, March 28, 2019 – The newly merged NEOMED-LABS / Pacific Biomarkers, an immunology centric service […]

read more

Ampersand Capital Partners Acquires Pacific Biomarkers and Merges Company with NEOMED-LABS

November 19, 2018 | Press Release

WELLESLEY, MA, LAVAL, QC, and SEATTLE, WA, November 19, 2018 - Ampersand Capital Partners announced today that it has completed […]

read more

FDA Qualifies Safety Biomarker Panel Developed and Validated by Pacific Biomarkers for Kidney Injury

September 24, 2018 | Press Release

SEATTLE, WASHINGTON, November 5, 2018 – The U.S. Food and Drug Administration (FDA), announced that the qualification of the Predictive […]

read more

1 2 3

back to top
contact us now

contact us

  • This field is for validation purposes and should be left unchanged.